## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `ss-31-trigeminal`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/ss-31-trigeminal/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-trigeminal/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-trigeminal/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/ss-31-trigeminal/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-trigeminal/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/ss-31-trigeminal/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `ss-31-trigeminal` v2 · content_hash `e4106cca736bfc19…` · thread_head genesis · 18 DIVs
- **thesis (c1):** Shan et al. 2023 mouse study showed SS-31 reversed mitochondrial damage in TNC and reduced nociceptive responses in inflammatory soup headache model.
  - c3 [human/active] No human trials test SS-31 for trigeminal neuralgia or TNC pain.
  - c2 [mechanistic/active] SS-31 binds cardiolipin to stabilize mitochondrial inner membrane and reduce ROS.
  - c4 [anecdotal/active] Reddit users report headaches as possible side effect during SS-31 dosing in CFS contexts.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/ss-31-trigeminal/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/ss-31-trigeminal/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `ss-31-trigeminal`
- **title:** SS-31 (Elamipretide) for Trigeminal Issues: Mitochondrial Repair Evidence
- **url:** https://miscsubjects.com/a/ss-31-trigeminal
- **register:** source_ledger
- **updated:** 2026-07-17T02:42:10.995Z
- **tags:** peptide, matrix

## Body

## What's breaking down

Trigeminal conditions often involve the trigeminal nerve and its central processing in the trigeminal nucleus caudalis (TNC) in the brainstem. One key degenerative layer is mitochondrial dysfunction inside neurons and glia there. Mitochondria produce ATP for nerve signaling and maintenance. When they falter, reactive oxygen species rise, energy drops, and cells struggle to repair damage or dampen overactive pain pathways. This can sustain neuropathic pain or headache-like responses even after initial triggers fade. Repair pathways that restore mitochondrial membrane integrity and electron transport could slow this breakdown. Symptom suppression alone leaves the energy deficit unaddressed.

## Why SS-31 (Elamipretide) might help you

If mitochondrial impairment in the TNC is part of your trigeminal picture, SS-31 targets that layer directly. It binds cardiolipin in the inner mitochondrial membrane. This stabilizes the membrane, supports efficient electron transport, and cuts excess ROS production. The result is better ATP output and less oxidative stress on nerve cells. In a mouse model of repeated inflammatory soup infusion that mimics aspects of headache and affects the TNC, SS-31 reversed mitochondrial ultrastructure damage, restored homeostasis markers, and reduced nociceptive behaviors. The study linked this to a Sirt3/PGC-1α feedback loop that supports mitochondrial biogenesis. Therefore, if your symptoms trace to energy-starved trigeminal neurons, SS-31 is discussed for its studied role in tissue-level mitochondrial repair rather than masking pain signals.

## How these fit together

Single-compound focus. SS-31 addresses the mitochondrial layer. If your profile includes other degeneration layers, separate compounds would target those without overlap in mechanism here.

## What the evidence actually shows

One preclinical study (mouse) directly examined SS-31 in a headache model involving the trigeminal nucleus caudalis. Shan et al. (2023) infused inflammatory soup repeatedly into mice, which impaired mitochondrial function, ultrastructure, and homeostasis in the TNC. SS-31 treatment reversed those mitochondrial changes and alleviated nociceptive responses via the Sirt3/PGC-1α loop. This is animal data only. No human trials test SS-31 specifically for trigeminal neuralgia or TNC-related pain. Broader SS-31 research includes preclinical models of neurodegeneration, ischemia, and inflammation where it protects mitochondrial function. Human data exist for primary mitochondrial myopathy and heart failure (Phase 2/3 trials showing improved exercise capacity or cardiac parameters in some cohorts), but these do not address trigeminal conditions. Tier: preclinical for trigeminal-specific findings; human for general mitochondrial disease contexts.

## What scientists say

Researchers note SS-31's selective accumulation in mitochondria without relying on membrane potential. It interacts with cardiolipin to optimize respiration and limit permeability transition pore opening. In the 2023 headache paper, authors conclude that improving mitochondrial function shows promise for migraine-related mechanisms. Reviews on mitochondrial peptides highlight consistent preclinical neuroprotection but call for more targeted human studies in pain or cranial nerve disorders. No large-scale endorsements exist for trigeminal use.

## What people say on Reddit

Anecdotal reports center on SS-31 use in chronic fatigue or mitochondrial support contexts. Some users describe temporary headaches or migraines during initial dosing, sometimes resolving or managed with other agents. Others report energy improvements without direct mention of trigeminal relief. No widespread threads detail trigeminal neuralgia outcomes. Experiences remain individual and unverified. Tier: anecdotal.

## What people say on X

Public posts discuss SS-31 in longevity or mitochondrial health circles. Mentions of trigeminal-specific effects are absent. General comments note interest in its mechanism or access issues post-regulatory changes. No detailed patient reports on trigeminal neuralgia appear in searchable posts. Tier: anecdotal.

## What we do not know

No human clinical trials exist for SS-31 in trigeminal neuralgia, migraine with TNC involvement, or similar conditions. Long-term effects on nerve regeneration or pain chronicity remain untested in people. Optimal use alongside other approaches lacks data. Individual mitochondrial variation and exact contribution to any one person's trigeminal symptoms are unclear from current evidence.

## Safety and limits

In published trials for mitochondrial myopathy and related indications, SS-31 showed generally good tolerability with mild side effects such as injection-site reactions in some participants. Preclinical work reports no major toxicity at studied doses. Human data remain limited outside specific disease trials. It is not approved for trigeminal conditions. Research access occurs via trials or specific programs where available. Always consult primary sources and medical professionals for personal decisions. Evidence inventory: 1 key animal study on trigeminal nucleus; multiple animal models for mitochondrial protection; several human trials in mitochondrial disease (not trigeminal); scattered anecdotal reports without trigeminal focus.

## Claims (4)

- **c3** [human w=0.8] No human trials test SS-31 for trigeminal neuralgia or TNC pain.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c1** [preclinical w=0.5] Shan et al. 2023 mouse study showed SS-31 reversed mitochondrial damage in TNC and reduced nociceptive responses in inflammatory soup headache model.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c2** [mechanistic w=0.3] SS-31 binds cardiolipin to stabilize mitochondrial inner membrane and reduce ROS.
  - who_claims: grok/grok-4.3
  - sources: s2
- **c4** [anecdotal w=0.3] Reddit users report headaches as possible side effect during SS-31 dosing in CFS contexts.
  - who_claims: grok/grok-4.3
  - sources: s3

## Voxel graph (4 atoms · 8 edges)
- full graph: https://miscsubjects.com/api/articles/ss-31-trigeminal/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (3)
- chain valid: yes · head: `15a6a77520823179`

### s1 · pubmed · ok
- title: SS-31 alleviated nociceptive responses and restored mitochondrial function in a headache mouse model via Sirt3/PGC-1α positive feedback loop
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC10240765/
- summary: Mouse study linking SS-31 to TNC mitochondrial repair and reduced pain behaviors.
- quote: Our results showed that repeated IS infusion impaired mitochondrial function, mitochondrial ultrastructure and mitochondrial homeostasis in the trigeminal nucleus caudalis (TNC). These IS-induced damages in TNC were reversed by SS-31. In addition, IS-induced nociceptive responses were simultaneously alleviated.
- claim_ids: c1, c3
- hash: `7f888b58592f2ef6`

### s2 · review · ok
- title: SS-31 (also known as Elamipretide®, Bendavia®, and MTP-131) Cognitive Vitality For Researchers
- url: https://www.alzdiscovery.org/uploads/cognitive_vitality_media/SS-31-Cognitive-Vitality-For-Researchers.pdf
- summary: Mechanism review of cardiolipin binding and mitochondrial effects.
- quote: SS-31 binds to cardiolipin, a lipid exclusively expressed on the inner mitochondrial membrane... modulates the hydrophobic interaction between cytochrome c and cardiolipin and function of cytochrome c.
- claim_ids: c2
- hash: `c281d912f12facb0`

### s3 · reddit · ok
- title: My Experience Treating my ME/CFS with mitochondrial peptides
- url: https://www.reddit.com/r/cfs/comments/1j2upcm/my_experience_treating_my_mecfs_with/
- summary: User report of migraine-like side effect with SS-31.
- quote: My second dosage given my shortness of breathe and an awful migraine.
- claim_ids: c4
- hash: `15a6a77520823179`

## Provenance (2 model passes)
- chain valid: yes · head: `71b05dd73ff02612`

- write · grok/grok-4.3 · 2026-06-29T23:45 · hash `8835fb8de5b0`
- voxel_divide · owner · 2026-07-17T02:42 · hash `71b05dd73ff0`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/ss-31-trigeminal/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/ss-31-trigeminal/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"ss-31-trigeminal","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest ss-31-trigeminal|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim ss-31-trigeminal|tier|assertion`
- **iMessage ask:** `ss-31-trigeminal|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `ss-31-trigeminal`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-trigeminal/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-trigeminal/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*